Orthofix Medical Inc. revised earnings guidance for the year 2024. For the year, the company expects net sales to range between $790 million to $795 million, representing implied growth of 6% to 7% year-over-year on a constant currency basis; narrowed from previous guidance of $785 million to $795 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.87 USD | +2.06% | -1.59% | +10.31% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.31% | 547M | |
-5.31% | 182B | |
-1.21% | 114B | |
-5.53% | 67.76B | |
+1.22% | 51.91B | |
+7.03% | 43.23B | |
+4.85% | 41.07B | |
+21.96% | 32.07B | |
+13.67% | 25B | |
-4.81% | 24.55B |
- Stock Market
- Equities
- OFIX Stock
- News Orthofix Medical Inc.
- Orthofix Medical Inc. Revises Earnings Guidance for the Year 2024